The bill extends coverage to more than 30 million uninsured Americans, funded partly by $121 billion in taxes on drug manufacturers, device makers and insurers. The health plans said they won’t back the legislation because it lets people buy insurance only when they need it, raising the costs for those who stay covered.
“What they came to realize is there are lots of ways they can get hurt without a public plan,” said John Sullivan, director of research at the health-care investment bank Leerink Swann & Co., in a telephone interview.
“One way is to have health plans full of sick people.” NOOOOOOOOOOOOOO! Not that :scared: Who would invest in a drug company that does THAT!?!?!?
http://www.bloomberg.com/apps/news?pid=20601103&sid=a.3Ph64SNtnQ